Fulgent Genetics Raises FY2026 Adj EPS Guidance from $(2.35)-$(2.22) to $(1.75)-$(1.65) vs $(2.27) Est; Affirms FY2026 Sales Guidance of $330.000M-$340.000M vs $331.700M Est
Benzinga Newsdesk 1 day ago
NewsGuidance
Fulgent Genetics (NASDAQ:FLGT) raises FY2026 Adj EPS guidance from $(2.35)-$(2.22) to $(1.75)-$(1.65) vs $(2.27) analyst estimate. Affirms FY2026 sales outlook from $330.000 million-$340.000 million to $330.000
Fulgent Genetics (NASDAQ:FLGT) raises FY2026 Adj EPS guidance from $(2.35)-$(2.22) to $(1.75)-$(1.65) vs $(2.27) analyst estimate. Affirms FY2026 sales outlook from $330.000 million-$340.000 million to $330.000 million-$340.000 million vs $331.700 million estimate.